Although TNF-α has a pivotal role in the pathogenesis of EAN and GBS [28], no significant change of its secretion by macrophage was observed after 2-DG (1 mM) treatment in vitro (Fig. 8d). The gene discussed is TNF; the disease is Guillain-Barre syndrome.